AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Clinical trial NCT06793371 · RECRUITING

Trial details

NCT number: NCT06793371
Sponsor: Cytokinetics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)

Start date: 2025-02-06
Primary completion: 2026-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.